<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05118399</url>
  </required_header>
  <id_info>
    <org_study_id>UW21-046</org_study_id>
    <nct_id>NCT05118399</nct_id>
  </id_info>
  <brief_title>Liposomal Bupivacaine for Supraclavicular Brachial Block in DR Surgery</brief_title>
  <official_title>The Analgesic Effect of Adding Liposomal Bupivacaine to Long-acting Local Anaesthetic for Supraclavicular Brachial Plexus Block in Distal Radial Fracture Surgery: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Brachial plexus blocks (BPB) are commonly used to provide regional anaesthesia for patients&#xD;
      undergoing distal radial fracture surgery. Distal radial (DR) fracture surgery is a commonly&#xD;
      performed orthopaedic surgery, and is usually associated with moderate postoperative pain.&#xD;
      Poor postoperative pain control can impair rehabilitation, delay recovery and negatively&#xD;
      impact outcomes after surgery. Liposomal bupivacaine (EXPAREL) is a multivesicular&#xD;
      formulation of bupivacaine that allows rapid absorption and prolonged release of bupivacaine.&#xD;
      Liposomal bupivacaine can provide longer analgesia for up to 72 hours, and may therefore&#xD;
      achieve greater analgesic efficacy compared to non-liposomal long-acting local anaesthetics.&#xD;
      A number of clinical trials have studied the effect liposomal bupivacaine given as local&#xD;
      infiltration. However, there is little evidence on liposomal bupivacaine for regional nerve&#xD;
      blocks, and the use of liposomal bupivacaine for supraclavicular brachial plexus block -&#xD;
      which is used for regional anaesthesia for distal radial fracture surgery - have not been&#xD;
      studied before. This project is a randomized controlled trial to determine whether adding&#xD;
      liposomal bupivacaine to long-acting local anaesthetics for supraclavicular BPB will improve&#xD;
      and prolong postoperative analgesia in patients undergoing distal radial fracture surgery.&#xD;
      Longer term secondary outcomes would be accessed including upper limb functional scores,&#xD;
      chronic pain, and health related quality of life.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain score at rest</measure>
    <time_frame>Hourly from 0 hour after surgery to 6 hours after surgery</time_frame>
    <description>Pain severity would be rated at rest after surgery using numerical rating scale with 0 to 10 where 0=no pain and 10=the worst possible pain</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Acute Pain</condition>
  <arm_group>
    <arm_group_label>To receive supraclavicular BPB using standard ropivacaine only.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20ml of plain bupivacaine will be injected using 2 syringes, so 10ml of 0.5% plain bupivacaine will be injected, and immediately followed by another 10ml of 0.5% plain bupivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>To receive supraclavicular BPB using liposomal bupivacaine together with ropivacaine.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10ml of 0.5% plain bupivacaine will be injected, and immediately followed by 10ml of 1.33% liposomal bupivacaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Injection [Marcaine]</intervention_name>
    <description>Bupivacaine injection [Marcaine] is the standard treatment used in our hospital.</description>
    <arm_group_label>To receive supraclavicular BPB using standard ropivacaine only.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Liposome 13.3 MG/ML [Exparel]</intervention_name>
    <description>Bupivacaine liposome is a multivesicular formulation of bupivacaine that allows rapid absorption and prolonged release of bupivacaine.</description>
    <arm_group_label>To receive supraclavicular BPB using liposomal bupivacaine together with ropivacaine.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologist (ASA) status I-III&#xD;
&#xD;
          -  Age 18-90 years old&#xD;
&#xD;
          -  Scheduled for distal radial fracture fixation (Open reduction and internal fixation&#xD;
             with volar approaching locking plate)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Revision surgery&#xD;
&#xD;
          -  Previous fractures or surgery in the affected distal radius&#xD;
&#xD;
          -  Surgery involving more than the affected arm&#xD;
&#xD;
          -  Higher energy and high-grade fracture cases - road traffic accident, fall from height,&#xD;
             open fractures, combined distal radius and distal ulna fractures, fractures requiring&#xD;
             external fixation, fractures with severe articular comminution or severe metaphyseal&#xD;
             extension, comminuted fractures requiring more than a single volar approach incision&#xD;
             and a single volar locking plate implant&#xD;
&#xD;
          -  Cases with painful conditions affecting the upper limb prior to surgery such as&#xD;
             cervical spine, shoulder, elbow, other hand and wrist problems&#xD;
&#xD;
          -  Cases with baseline (pre-injury) qDASH score worse than 10 out of 100&#xD;
&#xD;
          -  Respiratory compromise (requires long term oxygen)&#xD;
&#xD;
          -  History of seizures&#xD;
&#xD;
          -  Pre-existing neurological disorder/deficit&#xD;
&#xD;
          -  Chronic opioid user&#xD;
&#xD;
          -  Presence of chronic pain condition (pain duration over 3 months)&#xD;
&#xD;
          -  Alcohol or substance abuse&#xD;
&#xD;
          -  Active smoker&#xD;
&#xD;
          -  Psychiatric illness&#xD;
&#xD;
          -  Impaired mental state&#xD;
&#xD;
          -  Local infection&#xD;
&#xD;
          -  Allergy to analgesic drugs: local anaesthetic drugs, paracetamol, non-steroidal&#xD;
             anti-inflammatory drugs (NSAIDs), opioids&#xD;
&#xD;
          -  Impaired renal function (defined as effective glomerular filtration rate less than&#xD;
             30ml/min/1.73m2&#xD;
&#xD;
          -  Impaired liver function (defined as plasma bilirubin over 34micromol/L; international&#xD;
             normalized ratio [INR] 》／=1.7, alanine aminotransferase [ALT] over 100U/L, aspartate&#xD;
             aminotransferase [AST] over 100U/L)&#xD;
&#xD;
          -  Coagulopathy (platelet count 《100,000/ml and/or INR 》／=1.5) or the use of&#xD;
             anticoagulants (not including aspirin) that precludes the use of supraclavicular BPB&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Patient refusal for regional nerve blocks&#xD;
&#xD;
          -  Patient refusal to join the clinical trial&#xD;
&#xD;
          -  Patient unable/unwilling to attend post-op rehabilitation programme&#xD;
&#xD;
          -  Injury on duty&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stanley SC Wong, MD, MBBS</last_name>
    <phone>22553303</phone>
    <email>wongstan@hku.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chi Wai CW Cheung, MD, MBBS</last_name>
    <phone>22553303</phone>
    <email>cheucw@hku.hk</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 1, 2021</study_first_submitted>
  <study_first_submitted_qc>November 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Wong Sau Ching Stanley</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

